HCPCS A0433: Advanced Life Support, Level 2 (ALS 2)
HCPCS Level II code A0433 denotes Advanced Life Support, Level 2 (ALS 2), an ambulance transport service for patients requiring high‑acuity prehospital care. As a nationally recognized ambulance service code, A0433 captures situations where advanced airway management, multiple intravenous medications, or other complex ALS interventions are delivered during emergency transport. Its proper use affects claims accuracy, payment adjudication, and quality reporting for emergency medical services.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, United Healthcare, and Medicare. Readers will find an explanation of the clinical context for ALS 2 transports, comparisons to related ambulance codes, and typical scenarios that justify use of A0433. The publication also summarizes common billing considerations and claims elements associated with advanced life support ambulance services.
The content is intended to inform coding staff, billing managers, and policy analysts about the scope and application of A0433, outline where it fits among related ambulance service codes, and provide concise context for payer interactions and claims processing. Data not available in the input is noted where relevant.
Customize your policy alerts
Sign up for hcpcs A0433 policy alerts
Get alerted when payer policies referencing A0433 are released or updated.
Monitor payer policy activity
Billing Code Overview
HCPCS Level II code A0433 describes Advanced life support, level 2 (ALS 2). This service represents advanced prehospital care provided by trained emergency medical personnel for patients with serious or life‑threatening conditions requiring advanced airway management, multiple intravenous medications, or other advanced interventions beyond basic life support.
Service Type: Advanced life support (ALS) emergency transport
Typical Site of Service: Ambulance transport in prehospital or interfacility emergency settings
National Reimbursement Benchmarks
National commercial reimbursement for HCPCS A0433 centers around BUCA’s average commercial rate of $742.90, which provides a midpoint reference among major payers. Blue Cross Blue Shield’s dispersion (P75–P25) is $295.00 ($916.80–$620.30), while UnitedHealth Group shows a narrower interquartile spread of $200.90 ($789.80–$587.90). Aetna’s IQR is $116.00 ($689.00–$573.00) and Cigna’s is $330.90 ($767.60–$413.70). These differences indicate that Blue Cross Blue Shield and Cigna exhibit wider variability in commercial payment levels, whereas Aetna and UnitedHealth Group are comparatively tighter around their central tendencies.
Looking at central tendency and tails, UnitedHealth Group and Blue Cross Blue Shield have higher upper-end Q3 values ($789.80 and $916.80 respectively), suggesting higher payments are attainable at the 75th percentile, while Cigna’s median sits at $413.70. BUCA’s mean of $742.90 sits between several payers’ medians and upper quartiles, reflecting its role as an average commercial anchor in the national landscape. The IQR comparisons underscore where commercial rates cluster tightly versus where they spread widely across payers.